Total meso-pancreas excision: Key point of resection in pancreatic head adenocarcinoma

Hepato-Gastroenterology

Volumn 58, Issue 105, 2011, Pages 202-207

  Popescu, Irinel ^a   Dumitrascu, Traian ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Artery first; Creas excision; Negative resection margin; Pancreatic cancer; Posterior approach; Total meso pan

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MESO PANCREAS EXCISION; PANCREAS ADENOCARCINOMA; PANCREAS HEAD ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL APPROACH;

ADENOCARCINOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955045654     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225-249.
2. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46(4):765-781.
3. Beger HG, Rau B, Gansauge F, Poch B, Link KH: Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003;27(10):1075-1084. (Pubitemid 37259985)
4. Howard JM: Development and progress in resective surgery for pancreatic cancer. World J Surg 1999;23(9):901-906.
5. Kausch W: [Das Carcinom der Papilla duodeni und seine radikale Entfernung] in German. Beitr Z Klin Chir 1912; 78:439-486.
6. Whipple AO, Parsons WB, Mullins CR: Treatment of carcioma of the ampulla of Vater. Ann Surg 1935; 102(4):763-779.
7. Howard JH: Historical aspects and the future of pancreatoduodenectomy. In: Hanyu F, Takasaki K, editors. Pancreatoduodenectomy. Tokyo: Springer-Verlag, 1997: 3-10.
8. Jones L, Russell C, Mosca F, Boggi U, Sutton R, Slavin J, et al: Standard Kausch-Whipple pancreatoduodenectomy. Dig Surg 1999;16(4):297-304.
9. Buchler MW, Kleeff J, Friess H: Surgical treatment of pancreatic cancer. J Am Coll Surg 2007;205(4 Suppl): S81-S86.
10. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995;82(1):111-115.
11. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al: Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232(6):786-795.
12. Ionescu M, Stroescu C, Barbuta S, Ciurea S, Popescu I: {Pancreatoduodenectomy-the routin surgery?] in Romanian. Chirurgie 2003;98(2):103-108.
13. Buchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z'graggen K: Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003;138(12):1310-1314.
14. Dumitrascu T, David L, Popescu I: Posterior versus standard approach in pancreatoduodenectomy: a casematch study. Langenbecks Arch Surg 2009; May 6. [Epub ahead of print].
15. van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, et al: Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005;242(6):781-788.
16. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talmini MA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997; 226(3):248-257.
17. Andren-Sandberg A, Ihse I: Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg 1983;198(5):605-610.
18. Launois B, Huguier M: [Evidence based surgery of cancer of head of pancreas] in French. Bull Acad Natl Med 2004;188(5):743-752.
19. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al: A randomized trial of chemo radiotherapy and chemotherapy after resection of pancre atic cancer. N Engl J Med 2004;350(12):1200-1210. (Pubitemid 38339364)
20. Neoptolemos JP, Buchler MW, Stocken DD, Ghaneh P, Smith D, Bassi C, et al: ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol 2009; 27(18S):LBA4505.
21. Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, et al: Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008;247(3):456-462.
22. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, et al: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4(6):567-579.
23. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW: Curative resection is the single most im portant factor determining outcome in patients with pan creatic adenocarcinoma. Br J Surg 2004;91(5):586-594. (Pubitemid 38624667)
24. Hackert T, Buchler MW, Werner J: Surgical options in the management of pancreatic cancer. Minerva Chir 2009;64(5):465-476.
25. Beger HG, Rau B, Gansauge F, Leder G, Schwartz M, Poch B: Pancreatic cancer-low survival rates. Dtsch Arztebl Int 2008; 105(14):255-262.
26. Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, et al: Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma. Ann Surg 2010;251(6):1003-1010.
27. Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, et al: Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 2009;38(6):605-612.
28. Gaedcke J, Gunawan B, Grade M, Szoke R, Liersch T, Becker H, et al: The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg 2010;395(4):451-458.
29. Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, et al: Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg 2010;199(5): e65-e68.
30. Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I, et al: Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancre at Surg 2004;11(6):402-408. (Pubitemid 40069190)
31. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, et al: Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141(5):610-618. (Pubitemid 46616937)
32. Schmidt CM, Giant J, Winter JM, Kennard J, Dixon J, Zhao Q, et al: Total pancreatectomy (RO resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 2007;142(4):572-578.
33. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al: Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer 2008;14(8):5.
34. Neuhaus P, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al: Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234(6):758-768. (Pubitemid 33117196)
35. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hira bayashi K, Igarashi S: Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 2006; 10(4):511-518. (Pubitemid 43619152)
36. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K, et al: Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995;19(4):653-659.
37. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al: Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008; 15(6):1651-1660.
38. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A: Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93(10):1232- 1237.
39. Pissas A: Anatomoclinical and anatomosurgical essay on the lymphatic circulation of the pancreas. Anat Clin 1984; 6(4):255-280.
40. Pessaux P, Rosso E, Panaro F, Marzano E, Oussoultzoglou E, Bachellier P, et al: Preliminary experience with the hanging maneuver for pancreaticoduodenectomy. Eur J Surg Oncol 2009;35(9):1006-1010.
41. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC: Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993;217(2):144-148.
42. Buchler MW, Werner J, Weitz J: R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? Ann Surg 2010;251(6):1011-1012.
43. Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T: Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol 2007;5:44.
44. Pessaux P, Regenet N, Arnaud JP: [Resection of the retroportal pancreatic lamina during a cephalic pancreaticoduodenectomy: first dissection of the superior mesenteric artery] in French. Ann Chir 2003;128(9):633-636.
45. Pessaux P, Varma D, Arnaud JP: Pancreaticoduo denectomy: superior mesenteric artery first approach. J Gastrointest Surg 2006; 10(4):607-611. (Pubitemid 43619154)
46. Popescu I, David L, Dumitra AM, Dorobantu B: The posterior approach in pancreaticoduodenectomy: prelimi nary results. Hepatogastroenterology 2007; 54(75):921-926. (Pubitemid 46903754)
47. Agrawal MK, Thakur DS, Somashekar U, Chandrakar SK, Sharma D: Mesopancreas: myth or reality? JOP 2010;11(3):230-233.
48. Luttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Kloppel G: The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 1998;433:237-242.
49. Weitz J, Rahbari N, Koch M, Buchler MW: The "artery first" approach for resection of pancreatic head cancer. J Am Coll Surg 2010;210(2):e1-e4.
50. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery-the clue to pelvic recurrence? Br J Surg 1982;69(10):613-616.
51. Varty PP, Yamamoto H, Farges O, Belghiti J, Sau vanet A: Early retropancreatic dissection during pancre aticoduodenectomy. Am J Surg 2005;189(4):488-491. (Pubitemid 40488250)
52. Machado MC, Penteado S, Cunha JE, Jukemura J, Herman P, Bacchella T, et al: Pancreatic head tumors with portal vein involvement: an alternative surgical ap proach. Hepatogastroenterology 2001;48(41):1486-1487. (Pubitemid 33010452)
53. Horiguchi A, Ishihara S, Ito M, Nagata H, Shimizu T, Furusawa K, et al: Pancreatoduodenectomy in which dissection of the efferent arteries of the head of the pan creas is performed first. J Hepatobiliary Pancreat Surg 2007;14(6):575-578. (Pubitemid 350201469)
54. Brasoveanu V, Dumitrascu T, Bacalbasa N, Zamfir R: Splenic artery used for replaced common hepatic artery reconstruction during pancreatoduodenectomy - a case report. Chirurgia 2009;104(4):499-504.
55. Weitz J, Kienle P, Schmidt J, Friess H, Buchler MW: Portal vein resection for advanced pancreatic head can cer. J Am Coll Surg 2007;204(4):712-716. (Pubitemid 46428561)
56. Nakao A, Takagi H: Isolated pancreatectomy for pan creatic head carcinoma using catheter bypass of portal vein. Hepatogastroenterology 1993; 40(5):426-429. (Pubitemid 23310259)
57. Nakao A, Takagi H: Disseminated Intravascular Coagu lation (DIC) in the Intestinal Circulation by Acute Portal Vein Occlusion and the Effectiveness of Portal-Venous Bypass using an Antithrombogenic Caheter. Hepatogas troenterology 1993;40(5):167-172. (Pubitemid 23135853)
58. Nakao A, Takeda S, Inoue S, Nomoto S, Kanazumi N, Sugimoto H, et al: Indications and techniques of extended resection for pancreatic cancer. World J Surg 2006; 30(6):976-982. (Pubitemid 43824406)
59. Siriwaerana HP, Siriwardena AK: Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006;93(6):662-673.
60. Baulieux J, Adham M, Oussoultzoglou E, De la Roche E, Berthoux N, Bourdeix O, et al: [Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?] in French. Chirurgie 1998;123(5):438-444.
61. Tuech JJ, Pessaux P, Arnaud JP: Portal vein resection in pancreatic head carcinoma. Part 1: Technical considerations. Hepatogastroenterology 2001;48(39):884-887.
62. Nakao A, Kaneko T: Intravascular ultrasonography for assessment of portal vein invasion by pancreatic carci noma. World J Surg 1999;23(9):892-895. (Pubitemid 29398469)
63. Kaneko T, Nakao A, Inoue S, Nomoto S, Nagasaka T, Nakashima N, et al: Extrapancreatic nerve plexus invasion by carcinoma of the head of the pancreas. Diag nosis with intraportal endovascular ultrasonography. Int J Pancreatol 1996;19(1):1-7. (Pubitemid 26078915)